IFNAR1 and infection: In Fig. 1A, wild type (WT) and Ifnar1-/- mice (both BALB/c background, n = 10) were injected with 50 μg of VLPs 24h after infection by the mouse adapted (ma) EBOV, and the morbidity and mortality were checked daily for the subsequent 14 days.